Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – Still a Buy?

Shares of Novozymes A/S (OTCMKTS:NVZMY) saw strong trading volume on Tuesday . 79,870 shares changed hands during mid-day trading, an increase of 107% from the previous session’s volume of 38,560 shares.The stock last traded at $61.89 and had previously closed at $61.73.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 25th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, Novozymes A/S currently has a consensus rating of “Hold”.

Novozymes A/S Trading Up 0.7%

The firm has a market capitalization of $29.10 billion, a P/E ratio of 36.77, a P/E/G ratio of 1.15 and a beta of 0.96. The company has a current ratio of 1.75, a quick ratio of 1.07 and a debt-to-equity ratio of 0.28. The firm has a 50-day moving average of $62.06 and a two-hundred day moving average of $66.22.

Novozymes A/S Cuts Dividend

The company also recently announced a dividend, which was paid on Thursday, September 11th. Shareholders of record on Wednesday, September 3rd were given a dividend of $0.1856 per share. This represents a yield of 88.0%. The ex-dividend date of this dividend was Tuesday, September 2nd. Novozymes A/S’s dividend payout ratio is currently 21.89%.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.